1,1,1,3,3,3-Hexafluoropropan-2-yl 4-[[2-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate

InChIKey	`GLGGKOKQRXGJIL-UHFFFAOYSA-N`
Compound Name	1,1,1,3,3,3-Hexafluoropropan-2-yl 4-[[2-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate
Canonical SMILES	`CN1CC2CN(c3cc(C(F)(F)F)ccc3CN3CCN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC3)CC2C1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	6.97
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q99685	MGLL	Homo sapiens	Human	PF12146	7.6	IC50	ChEMBL;BindingDB
Q13093	PLA2G7	Homo sapiens	Human	PF03403	6.4	IC50	ChEMBL;BindingDB